Magstim has launched INSIGHT, the first cloud-based electronic health record management solution for TMS practices (Mediwales, 2017). Magstim INSIGHT is a convenient and mobile platform created to securely store patient and TMS treatment information. American TMS providers will be able to share data remotely with co-workers, track patients’ progress and chart their treatment outcomes. It … Continue reading Magstim launches health record management solution

IBA, Royal Philips and Proton Partners International have announced that they will be collaborating to build the first compact proton therapy system in the Middle East (MediWales, 2017). The proton therapy centre will be part of a large existing hospital, the Gulf International Cancer Center. The proton therapy centre will be the first compact proton … Continue reading Proton Partners, IBA and Philips Join Forces in Cancer Care in the Middle East

A study into a new treatment for Sanfilippo disease, a rare and fatal condition which causes progressive dementia in children, is progressing well with results set to be published later this year (University of Manchester, 2017). Sanfilippo disease, also known as Mucopolysaccharidosis (MPS) III, currently has no effective treatment. It affects around one hundred and … Continue reading University of Manchester study testing new treatment for Sanfilippo disease progressing well

University of Manchester biologists have discovered that breast tissues have twenty four hour body clocks, and that several hundred genes are regulated in a daily cycle (University of Manchester, 2017). The discovery by Dr Qing-Jun Meng and Professor Charles Streuli, may offer the first evidence of a link between breast biology, including breast cancer risks, … Continue reading Inbuilt body clocks link breast stiffness to cancer risks

The University of Liverpool is to co-ordinate a new £14m European research project which aims to improve the understanding of adverse drug reactions by using cutting-edge modelling approaches to drug safety (University of Liverpool, 2017). Adverse drug reactions (ADRs) are the unwanted side effects of medication. They can contribute significantly to patient morbidity, mortality and … Continue reading University of Liverpool to coordinate £14m drug safety research project

The University of Manchester has, through its Innovation Company (UMI3), signed a licensing and research agreement with Douglas Pharmaceuticals that could save the lives of millions of women around the world suffering from early stage cervical cancer (University of Manchester, 2017). The deal initially sees New Zealand-based Douglas Pharmaceuticals sponsor research at Manchester University to … Continue reading Research agreement could prevent cervical cancer in millions of women

A British Heart Foundation Cymru funded research team led by Professor Alan Williams will be based at Swansea University Medical School from this month (Swansea University, 2017).‌ Swansea University Medical School will offer the opportunity for Alan Williams and his team to continue their unprecedented research in Wales with £2.3m of investment from BHF, after … Continue reading £2.3m BHF Cymru research hosted by Swansea University Medical School

For the first time, biologists have succeeded in growing human stem cells in pig embryos (The New York Times, 2017). The approach involves generating stem cells from a patient’s skin, growing the desired new organ in a large animal like a pig, and then harvesting it for transplant into the patient’s body. Since the organ … Continue reading Introducing pig-human embryos and a rat-mouse

Knitting and weaving artificial muscles could help create soft exoskeletons that people with disabilities could wear under their clothes to help them walk, according to new research (Scientific American, 2017). Researchers at Linköping University in Sweden have created actuators, devices that convert energy into motion, from cellulose yarn coated with a polymer that reacts to … Continue reading New exosuit fabric could boost mobility in people with disabilities

Targeting tangles of tau protein in mice with Alzheimer’s-like symptoms has reversed their brain damage, halting memory loss and extending their lives (New Scientist, 2017). Clumps of two types of sticky protein build up in the brains of people with Alzheimer’s disease; beta-amyloid plaques, and tangles of tau. While many attempts to develop drugs to … Continue reading Gene-blocking therapy advances Alzheimer’s-like symptoms in mice